
import { Component } from "@angular/core";

@Component({
  selector: 'profileDialog2',
  template: `<div class="profile-popups" fxLayoutAlign="end"><h2 fxFlex="90" matDialogTitle>Regulatory Information</h2>
						<button  class="md-icon-button close_button" aria-label="cancel" mat-raised-button [matDialogClose]="true">
							<i class="fa fa-close"></i>
						</button></div>
						<mat-dialog-content>
						<div>
							<div>
								<p><b>National Regulatory Authority(ies):</b></p>
								<p class="definition">This is a required level of review/approval for the site to initiate clinical research protocols. It is in addition to the Local Institution-level review or ethics committee.</p>
								<p id="ClinRegs">
									<a style="color: #0b00c8" href="https://clinregs.niaid.nih.gov/" target="blank">NIAID ClinRegs</a><br>
									<i>An online public database of country-specific clinical research regulatory information that enables users to explore and compare regulations across different countries. The website was created and is maintained by NIHâ€™s National Institute of Allergy and Infectious Diseases (NIAID).</i>
								</p>
								<mat-divider></mat-divider>
								
								<p><b>Institutional Review Board (IRB):</b></p>
								<p class="definition">A committee that performs ethical review of proposed research to be conducted at an Institution and is registered with the Office of Human Research Protections (OHRP).</p>
								<mat-divider></mat-divider>
								
								<p><b>Other IRB:</b></p>
								<p class="definition">Multiple IRBs may be associated with a single institution.</p>
								<mat-divider></mat-divider>
					
								<p><b>Institutional Biosafety Committee:</b></p>
								<p class="definition">The committees responsible for the oversight of recombinant DNA research.</p>
								<mat-divider></mat-divider>
					
								<p><b>Clinical Trials Insurance (CTI):</b></p>
								<p class="definition">Insurance for injury or damage to study participants that is sometimes required by national guidelines of countries participating in clinical trials.</p>
								<mat-divider></mat-divider>
					
								<p><b>Languages:</b></p>
								<p class="definition">The predominant language(s) spoken at a site and that which may be used for informed consent documents at the site.</p>
							</div>
						</div>
						</mat-dialog-content>`
})

export class profileDialog2Component {}
export default ( profileDialog2Component );